Siroboon - Sirolimus 1 mg Tabs

Sirolimus belongs to a class of medications known as mTOR inhibitors, which work by blocking a specific pathway involved in the activation and proliferation of immune cells called T-lymphocytes. By suppressing this immune activity, Sirolimus helps reduce the body's natural tendency to recognize and attack a transplanted organ as foreign, supporting long-term graft survival. It is commonly used following kidney transplantation, often in combination with other immunosuppressant medications, as part of a comprehensive anti-rejection treatment plan. The medication is typically taken orally, once daily, and is usually started after the initial post-transplant period under close medical guidance. Consistent, precise dosing is important with Sirolimus, and regular blood tests are typically used to monitor drug levels, helping ensure the medication remains at an effective and safe concentration. Ongoing monitoring of kidney function and overall health is also an important part of long-term care for transplant patients using this medication. Many patients experience successful, long-term protection of their transplanted organ with consistent use of Sirolimus as part of their treatment plan. Regular follow-up with a transplant care team helps support the best possible outcomes over time. As with all immunosuppressant therapies, Sirolimus should be used strictly under the guidance of a healthcare provider experienced in post-transplant care.